Trials / Terminated
TerminatedNCT00547456
Consequences of Nocturnal and Daytime Hypoxemia in COPD
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We will determine whether oxygen therapy lowers the level of substances in the blood which cause inflammation, which is one of the adverse effects of COPD and whether oxygen improves overall well being and quality of life as well as sleep quality.
Detailed description
Hypothesis: Isolated nocturnal hypoxemia contributes to chronic systemic inflammation in COPD by activating circulating neutrophils.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxygen | Oxygen 2-3L Nasal cannula |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2007-10-22
- Last updated
- 2015-12-16
- Results posted
- 2015-12-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00547456. Inclusion in this directory is not an endorsement.